HomeQuestion

How would you manage a patient with hidradenitis suppurativa and inflammatory arthritis (RA vs. PsA)?

3

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

When trying to increase infliximab for active disease (inflammatory arthritis or sarcoidosis), do you prefer to increase dosage or reduce frequency between doses?

In a patient with a history of seropositive erosive RA who has undergone treatment for a periprosthetic joint infection and currently has an antibiotic spacer in place with clinical improvement, what is the appropriate timing and strategy for restarting DMARDs and/or biologic therapy to balance infection risk with RA disease control?

What is your approach to diagnosing and managing methotrexate-induced alopecia?

How do you handle medication refills for patients on traditional DMARDs who are lost to follow-up?

How do you approach the use of immunosuppressive therapy in patients with rheumatoid arthritis and underlying immunodeficiency, such as IgA deficiency?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.